Validation of diabetic retinopathy and maculopathy diagnoses recorded in a U.K. primary care database

Diabetes Care

Volumn 35, Issue 4, 2012, Pages 762-767

  Martín Merino, Elisa ^a   Fortuny, Joan ^b   Rivero, Elena ^b   García Rodríguez, Luis Alberto ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b Novartis Farmaceutica S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PREDICTION; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; REFERENCE DATABASE; RETINA MACULOPATHY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; GREAT BRITAIN; HUMANS; INFANT; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUESTIONNAIRES; REGISTRIES; RETINAL DISEASES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862066647     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2069     Document Type: Article

References (22)

1. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-March 2000. Eye (Lond) 2008;22:905-911
2. Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond) 2004;18:963-983 (Pubitemid 39430033)
3. Genz J, Scheer M, Trautner C, Zöllner I, Giani G, Icks A. Reduced incidence of blindness in relation to diabetes mellitus in southern Germany? Diabet Med 2010;27:1138-1143
4. National Institute for Health and Clinical Excellence. Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults. Clinical Guideline 15. London: National Institute for Health, 2004. Available from http://guidance.nice.org.uk/CG15/NICEGuidance/pdf/English. Accessed 28 November 2011.
5. National Institute for Health and Clinical Excellence. Type 2 diabetes: the management of type 2 diabetes. Clinical Guideline 66. London: National Institute for Health, 2008. Available from http://www.nice.org.uk/nicemedia/pdf/ CG66NICEGuideline.pdf. Accessed 4 December 2011.
6. Ockrim Z, Yorston D. Managing diabetic retinopathy. BMJ 2010;341:c5400
7. The Royal College of Ophthalmologists. Scientific Department. Guidelines for Diabetic Retinopathy. Screening for diabetic retinopathy. Pages 35-39. London: The Royal College of Ophthalmologists, 2005. Available from http://www.rcophth.ac.uk/page.asp?section=451§ionTitle= Clinical+Guidelines. Accessed 18 October 2011.
8. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med 2003;20:758-765 (Pubitemid 41701472)
9. Facey K, Cummins E, MacPherson K, Morris A, Reay L, Slattery J. Organisation of services for diabetic retinopathy screening. In Health Technology Assessment Report 1. Glasgow, Health Technology Board for Scotland, 2002.
10. Data Statistics THIN. Cegedim Strategic Data Medical Research UK. Available from http://csdmruk.cegedim.com. Accessed 6 October 2011.
11. O'Neil M, Payne C, Read J. Read Codes Version 3: a user led terminology. Methods Inf Med 1995;34:187-192
12. Stuart-Buttle CD, Read JD, Sanderson HF, Sutton YM. A language of health in action: Read Codes, classifications and groupings. Proc AMIA Annu Fall Symp 1996:75-79
13. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004;12:171-177 (Pubitemid 39534583)
14. Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007;16:393-401 (Pubitemid 46656860)
15. Ruigómez A, Martín-Merino E, Rodríguez LA. Validation of ischemic cerebrovascular diagnoses in the health improvement network (THIN). Pharmacoepidemiol Drug Saf 2010;19:579-585
16. Margulis AV, García Rodríguez LA, Hernández- Díaz S. Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf 2009;18:900-909
17. González EL, Johansson S, Wallander MA, Rodríguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009;63: 332-336
18. Gonzalez-Perez A, Schlienger RG, Rodríguez LA. Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study. Diabetes Care 2010;33:2580-2585
19. Gunathilake W, Song S, Sridharan S, Fernando DJ, Idris I. Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes. QJM 2010; 103:881-884
20. Sloan FA, Brown DS, Carlisle ES, Ostermann J, Lee PP. Estimates of incidence rates with longitudinal claims data. Arch Ophthalmol 2003;121:1462-1468 (Pubitemid 37243749)
21. Bearelly S, Mruthyunjaya P, Tzeng JP, et al. Identification of patients with diabetic macular edema from claims data: a validation study. Arch Ophthalmol 2008; 126:986-989 (Pubitemid 352008384)
22. Jyothi S, Elahi B, Srivastava A, Poole M, Nagi D, Sivaprasad S. Compliance with the quality standards of National Diabetic Retinopathy Screening Committee. Prim Care Diabetes 2009;3:67-72